Skip to main content
Premium Trial:

Request an Annual Quote

NeuroTherapeutics Pharma Licenses Dotmatics Software for Chemistry Data Management

Premium

Dotmatics said this week that it has licensed its platform to NeuroTherapeutics Pharma, a Chicago Ill.-based biopharmaceutical company.

According to NTP, the company selected Dotmatics' platform to manage its chemistry research and development data.

NTP is using Dotmatic's Browser, Vortex, Gateway, Pinpoint, and Nucleus software tools in its efforts to develop compounds that treat pain, epilepsy, and other nervous system disorders.

Financial details of the licensing agreement were not disclosed.

Other recent licensees of Dotmatics' portfolio include Cancer Therapeutics CRC, Progenra, and Basilea Pharmaceutica (BI 6/8/2012), (BI 5/25/2012), and (BI 5/18/2012).

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.